POPULATION PHARMACOKINETICS OF AEDS AFTER CO-ADMINISTRATION WITH ESLICARBAZEPINE ACETATE IN ADULT PATIENTS WITH REFRACTORY PARTIAL EPILEPSY

被引:0
|
作者
Falcao, A. [1 ]
Fuseau, E. [2 ]
Fabre, M. A. [2 ]
Maia, Joana [3 ]
Almeida, Luis [3 ]
Soares-da-Silva, Patricio [3 ]
机构
[1] 4Hlth Consulting Ltd, Cantanhede, Portugal
[2] EMF Consulting, Aix En Provence, France
[3] BIAL Portela & Co, SA, Sao Mamede do Coronado, Portugal
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:430 / 430
页数:1
相关论文
共 50 条
  • [21] Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures
    Sunkaraneni, Soujanya
    Ludwig, Elizabeth A.
    Passarell, Julie A.
    Blum, David
    Grinnell, Todd
    Fiedler-Kelly, Jill
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (07): : 927 - 938
  • [22] THE DESIGN OF A PHASE III CLINICAL STUDY OF ESLICARBAZEPINE ACETATE IN ELDERLY PATIENTS WITH PARTIAL-ONSET SEIZURES IN EPILEPSY
    Nunes, T.
    Steinhoff, B. J.
    Costa, R.
    Pinto, R.
    Lopes, N.
    Soares-da-Silva, P.
    EPILEPSIA, 2011, 52 : 110 - 110
  • [23] Effect of chloroquine pre-treatment on the metoclopramide's pharmacokinetics after their co-administration
    Alotaibi, Badriyah Shadid
    Kaukab, Iram
    Shah, Syed Nisar Hussain
    Kharaba, Zelal
    Naeem, Abdul Rafay
    Yasin, Haya
    Umar, Muhammad Ihtisham
    Murtaza, Ghulam
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 213 - 219
  • [24] Pharmacokinetics, Drug Interactions and Exposure-Response Relationship of Eslicarbazepine Acetate in Adult Patients with Partial-Onset SeizuresPopulation Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses
    Amilcar Falcão
    Eliane Fuseau
    Teresa Nunes
    Luis Almeida
    Patricio Soares-da-Silva
    CNS Drugs, 2012, 26 : 79 - 91
  • [25] Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy
    Birnbaum, Angela K.
    Karanam, Ashwin
    Marino, Susan E.
    Barkley, Christopher M.
    Remmel, Rory P.
    Roslawski, Michaela
    Gramling-Aden, Mary
    Leppik, Ilo E.
    EPILEPSIA, 2019, 60 (08) : 1586 - 1592
  • [26] Population pharmacokinetics of daptomycin in patients with bone and joint infection: minimal effect of rifampicin co-administration and confirmation of a sex difference
    Garreau, Romain
    Bricca, Romain
    Gagnieu, Marie-Claude
    Roux, Sandrine
    Conrad, Anne
    Bourguignon, Laurent
    Ferry, Tristan
    Goutelle, Sylvain
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (05) : 1250 - 1257
  • [27] The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
    Davies, Simon J. C.
    Mulsant, Benoit H.
    Flint, Alastair J.
    Meyers, Barnett S.
    Rothschild, Anthony J.
    Whyte, Ellen M.
    Kirshner, Margaret M.
    Sorisio, Denise
    Pollock, Bruce G.
    Bies, Robert R.
    CLINICAL PHARMACOKINETICS, 2015, 54 (11) : 1161 - 1168
  • [28] The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
    Simon J. C. Davies
    Benoit H. Mulsant
    Alastair J. Flint
    Barnett S. Meyers
    Anthony J. Rothschild
    Ellen M. Whyte
    Margaret M. Kirshner
    Denise Sorisio
    Bruce G. Pollock
    Robert R. Bies
    Clinical Pharmacokinetics, 2015, 54 : 1161 - 1168
  • [29] Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy
    Patricia Hernandez-Mitre, Maria
    Edith Medellin-Garibay, Susanna
    Rodriguez-Leyva, Ildefonso
    Jazmin Rodriguez-Pinal, Cristian
    Zarazua, Sergio
    Helene Jung-Cook, Helgi
    Roberts, Jason A.
    Romano-Moreno, Silvia
    del Carmen Milan-Segovia, Rosa
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 109 (06) : 2070 - 2078
  • [30] Effects of probenecid on the pharmacokinetics of mizoribine and co-administration of the two drugs in patients with nephrotic syndrome
    Utsunomiya, Y.
    Hara, Y.
    Ito, H.
    Okonogi, H.
    Miyazaki, Y.
    Hashimoto, Y.
    Hosoya, T.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (11) : 751 - 755